AI Multi-Cancer Early Detection Blood Test (Spot-Mas)

Details

What is SPOT-MAS?

SPOT-MAS is a non-invasive screening test that analyzes circulating tumor DNA (ctDNA) from a single blood sample.

• Understanding ctDNA: When tumor cells die or undergo metabolism, their DNA breaks down into small fragments and is released into the bloodstream. These fragments carry unique, tumor-specific genetic mutation information.
• Next-Generation Sequencing: Utilizing just one 10 ml blood draw tube , DNA is extracted from plasma and sequenced using next-generation ctDNA technology to closely analyze multiple features of your DNA.
• Advanced Multi-Omics Technology: Unlike traditional single-omics tests, SPOT-MAS integrates Genomics, Fragmentomics, and Epigenomics. This multi-omics approach allows for multi-dimensional detection, making it significantly more comprehensive and sensitive.

Why Choose SPOT-MAS?

• 【Earlier Detection】 It can detect early-stage cancer signatures even earlier than traditional imaging tests.
• 【Outperforms Traditional Markers】 Outperforms standard tumor markers by offering 7–12X higher sensitivity and 10–14X higher positive predictive value (PPV).
• 【High Accuracy】 Boasts a 99.8% high accuracy rate , which strictly limits false positives and saves you from undergoing unnecessary, stressful follow-up work-ups.
• 【Broad Coverage】 Screens for 5 common and 5 aggressive cancers, covering nearly 70% of total cancer incidence. Notably, 9 out of 10 of these covered cancers are not currently covered by large-scale government screening programs.
• 【Extensively Validated in Asia】 It is the first MCED test to undergo prospective validation in an Asian cohort of over 9,024 participants. By applying big data analytics to massive datasets (20,000 cancer cases + 25,000 healthy controls), it successfully identifies key cancer signatures.

Comprehensive Screening Coverage: 10 Cancer Types

• Back pain
• Swelling in eyelids, abdomen and lower limbs
• Blood in urine, foamy or bubbly urine, increased nocturia or reduced urine output
• Hypertension
• Shortness of breath
• Fatigue or anaemia symptom
• Loss of appetite, nausea, vomiting and itchiness

Who Should Consider Taking the SPOT-MAS Test?

1. Adults Aged Over 40 Years
   (The risk of developing cancer increases with age and surges significantly starting from age 40; regular screening is highly recommended.)
2. Adults Aged Under 40 with Specific Cancer Risk Factors:

• Diabetes: The overall risk of cancer is 20% higher among individuals with diabetes compared to those without.
• Overweight or Obesity: Obesity is shown to increase overall cancer risk by approximately 10% to 200%.
• Familial History: Individuals who have family members previously diagnosed with cancer.
• Liver Diseases: Individuals living with Chronic Hepatitis B or Hepatitis C infections.
• Hereditary Risks: Individuals who have tested positive for inherited cancer predisposition genes such as BRCA1, BRCA2, or TP53.
• Heavy Smoking: Individuals with a 20 pack-year history of smoking.
• Heavy Drinking: Men who regularly consume more than 15 cans of beer a week, or women who consume more than 8 cans of beer a week.

Note: All product specifications, clinical performance statistics, and medical risks detailed on this e-shop page are sourced directly from the official SPOT-MAS Product Patient Leaflet.